Palisade Bio Inc (PALI)
5.36
-0.49
(-8.38%)
USD |
NASDAQ |
May 21, 16:00
5.36
0.00 (0.00%)
After-Hours: 20:00
Palisade Bio Total Liabilities (Quarterly): 2.588M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 2.588M |
| December 31, 2023 | 2.739M |
| September 30, 2023 | 2.985M |
| June 30, 2023 | 2.49M |
| March 31, 2023 | 1.515M |
| December 31, 2022 | 3.284M |
| September 30, 2022 | 3.836M |
| Date | Value |
|---|---|
| June 30, 2022 | 3.595M |
| March 31, 2022 | 3.558M |
| December 31, 2021 | 5.147M |
| September 30, 2021 | 12.35M |
| June 30, 2021 | 24.39M |
| December 31, 2020 | 19.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.515M
Minimum
Mar 2023
24.39M
Maximum
Jun 2021
6.777M
Average
3.558M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| TG Therapeutics Inc | 213.21M |
| Protagenic Therapeutics Inc | 0.6553M |
| Bio-Path Holdings Inc | 4.393M |
| Jaguar Health Inc | 43.57M |
| Finch Therapeutics Group Inc | 31.05M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.65M |
| Shareholders Equity (Quarterly) | 10.06M |